Moldy odor in bottles brings Tylenol 8-Hour recall

Johnson and Johnson has announced another Tylenol recall of drugs produced by McNeil Consumer Healthcare, one of its subsidiaries. The latest Tylenol recall is the fifth such action in 1 year for the pharmaceutical giant. The litany of product flaws has brought the attention of Congress, which has put the company’s quality control practices under investigation. A musty scent coming from the bottles triggered the latest recall of the popular over-the-counter medicine.

The recall means giving back any 8-hour Tylenol

Monday, more of the Tylenol recall had been announced. The McNeil Consumer Healthcare division of Johnson and Johnson’s got involved on its own. About 128,000 bottles of 50-count Tylenol 8-hour Caplets were taken back by the company. According to the New York Times, the recall had been started by McNeil because of a “musty or moldy odor” within the Tylenol 8-Hour. This was a complaint with U.S. and Puerto Rico products. The Tylenol recalled had been made at the company’s troubled Fort Washington, Pa., plant before the facility had been closed in March. The trigger of the recall is the very same excuse for why there was a Tylenol recall in January, June and July with merchandise made in Puerto Rico at the McNeil plant. They said a chemical used to treat wooden transport pallets that leached to the Tylenol probably caused there to be a musty smell.

Tylenol recalls over and over

Because Johnson and Johnson have had various recalls this year, Congress has decided to look into it. Due to nausea, stomach pain, vomiting and diarrhea, five lots of 100-count Tylenol Arthritis Pain were recalled, accounts Cable News Network, just last Nov. In Dec, the Tylenol recall had been expanded to all lots of the product. In January, the Tylenol recall had been expanded further to numerous lots of Tylenol, Motrin and other non-prescription drugs after consumer complaints of scent and nausea. Quality manage and safety concerns caused 50 children’s medicines to be in the recall in May.

Ensuring you manage factories much better

Johnson and Johnson closed the McNeil plant in April. Reuters accounts the business has since been revamping the plant’s quality control plans to address violations uncovered in an investigation by inspectors from the United States Food and drug administration. The FDA found thick dust, grime and contaminated drug ingredients. The plant in Fort Washington manufactured lots of drugs for Johnson and Johnson. About $650 million a year was made off the one plant. Bloomberg reports that the recalls and facility closings will reduce the company’s sales this year by about $600 billion.

Data from

New York Times

prescriptions.blogs.nytimes.com/2010/10/18/more-trouble-with-tylenol/?partner=rss and emc=rss

CNN

cnn.com/2010/HEALTH/10/19/tylenol.recall/index.html?npt=NP1

Reuters

reuters.com/article/idUSTRE69I2W320101019